Dashboard
Faculty
Programme
Login
Dashboard
Faculty
Programme
Login
Evolving the Clinical Utility of dd-cfDNA (AlloSure/AlloSeq cfDNA) in Organ Transplantation
Wednesday September 14, 2022 from 13:15 to 14:15
Room: A
Clinical utility of dd-cfDNA in kidney transplant surveillance
Log in to add to favorites
Add Personal Notes
Tarek Alhamad, United States
Washington University in St. Louis
Presentations by Tarek Alhamad
Mon-12 from 11:35 - 13:05 in room E
Biomarkers & monitoring
Acute Tubular Injury And Necrosis Do Not Lead To Meaningful Elevations In Donor-derived Cell-free DNA (dd-cfDNA)
Mon-12 from 16:25 - 17:25 in room C5
Pancreas 1
Survival after simultaneous pancreasâkidney transplantation in type 1 diabetes: The critical role of early pancreas allograft function
Mon-12 from 11:35 - 13:05 in room C5
Pancreas and islet
Outcomes in Mild Obese Recipients with Diabetes Mellitus Type 2 that received Simultaneous Kidney Pancreas Transplant
Wed-14 from 13:15 - 14:15 in room A
Evolving the Clinical Utility of dd-cfDNA (AlloSure/AlloSeq cfDNA) in Organ Transplantation
Clinical utility of dd-cfDNA in kidney transplant surveillance
Email:
info@tts2022.org
514-874-1717 x203
© 2024 TTS 2022